Effect of cilostazol on delayed cerebral vasospasm after subarachnoid hemorrhage in rats: Evaluation using black blood magnetic resonance imaging

Neurobiology of Disease

Volumn 32, Issue 1, 2008, Pages 157-161

  Ito, Hideki ^a   Fukunaga, Mari ^a   Suzuki, Hidenori ^b   Miyakoda, Goro ^a   Ishikawa, Makoto ^a   Yabuuchi, Youichi ^a   Taki, Waro ^b  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; CILOSTAZOL; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN VASOSPASM; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG EFFECT; MALE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE;

ANIMALS; MAGNETIC RESONANCE IMAGING; MALE; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE; TETRAZOLES; TIME FACTORS; VASOSPASM, INTRACRANIAL;

EID: 51349092362     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.07.004     Document Type: Article

References (32)

1. 2 alpha, in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage participates in the pathogenesis of delayed cerebral vasospasm. Neurosci. Lett. 373 (2005) 222-225
2. Barry K.J., Gogjian M.A., and Stein B.M. Small animal model for investigation of subarachnoid hemorrhage and cerebral vasospasm. Stroke 10 (1979) 538-541
3. Birk S., Edvinsson L., Olesen J., and Kruuse C. Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries. Eur. J. Pharmacol. 489 (2004) 93-100
4. Birk S., Kruuse C., Petersen K.A., Jonassen O., Tfelt-Hansen P., and Olesen J. The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow. J. Cereb. Blood Flow Metab. 24 (2004) 1352-1358
5. Brawley B.W., Strandness Jr. D.E., and Kelly W.A. The biphasic response of cerebral vasospasm in experimental subarachnoid hemorrhage. J. Neurosurg. 28 (1968) 1-8
6. Delgado T.J., Brismar J., and Svendgaard N.A. Subarachnoid haemorrhage in the rat: angiography and fluorescence microscopy of the major cerebral arteries. Stroke 16 (1985) 595-602
7. Dorhout Mees S.M., van den Bergh W.M., Algra A., and Rinkel G.J.E. Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Detabase Syst. Rev. 4 (2007) CD006184
8. Edelman R.R., Mattle H.P., Wallner B., Bajakian R., Kleefield J., Kent C., Skillman J.J., Mendel J.B., and Atkinson D.J. Extracranial carotid arteries: evaluation with "black blood" MR angiography. Radiology 177 (1990) 45-50
9. Fayad Z.A., Fuster V., Fallon J.T., Jayasundera T., Worthley S.G., Helft G., Aguinaldo J.G., Badimon J.J., and Sharma S.K. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 102 (2000) 506-510
10. Gallia G.L., and Tamargo R.J. Leukocyte-endothelial interactions in chronic vasospasm after subarachnoid hemorrhage. Neurol. Res. 28 (2006) 750-758
11. Gules I., Satoh M., Clower B.R., Nanda A., and Zhang J.H. Comparison of three rat models of cerebral vasospasm. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H2551-H2559
12. Hashimoto A., Miyakoda G., Hirose Y., and Mori T. Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism. Atherosclerosis 189 (2006) 350-357
13. Hirose H., Kimura T., Okada M., Itoh Y., Ishida F., Mochizuki N., Nishibe T., and Nishikibe M. Antiplatelet and antithrombotic effects of a novel selective phosphodiesterase 3 inhibitor, NSP-513, in mice and rats. Jpn. J. Pharmacol. 82 (2000) 188-198
14. Huang Y., Cheng Y., Wu J., Li Y., Xu E., Hong Z., Li Z., Zhang W., Ding M., Gao X., Fan D., Zeng J., Wong K., Lu C., Xiao J., and Yao C. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. Lancet Neurol. 7 (2008) 494-499
15. Ito H., Miyakoda G., and Mori T. Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation. Platelets 15 (2004) 293-301
16. Joo S.P., Kim T.S., Kim Y.S., Moon K.S., Lee J.K., Kim J.H., and Kim S.H. Clinical utility of multislice computed tomographic angiography for detection of cerebral vasospasm in acute subarachnoid hemorrhage. Minim. Invasive Neurosurg. 49 (2006) 286-290
17. Kambayashi J., Liu Y., Sun B., Shakur Y., Yoshitake M., and Czerwiec F. Cilostazol as a unique antithrombotic agent. Curr. Pharm. Des. 9 (2003) 2289-2302
18. Kanamaru K., Waga S., Kojima T., Fujimoto K., and Niwa S. Endothelium-dependent relaxation of canine basilar arteries. Part 2: Inhibition by hemoglobin and cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage. Stroke 18 (1987) 938-943
19. Kim K.Y., Shin H.K., Choi J.M., and Hong K.W. Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells. J. Pharmacol. Exp. Ther. 300 (2002) 709-715
20. Koktzoglou I., Chung Y., Carroll T.J., Simonetti O.P., and Morasch M.D. Three-dimensional black-blood MR imaging of carotid arteries with segmented steady-state free precession: Intial Experience. Radiology 243 (2007) 220-228
21. Kuroki M., Kanamaru K., Suzuki H., Waga S., and Semba R. Effect of vasospasm on heme oxygenases in a rat model of subarachnoid hemorrhage. Stroke 29 (1998) 683-689
22. Lee J.H., Lee Y.K., Ishikawa M., Koga K., Fukunaga M., Miyakoda G., Mori T., Hosokawa T., and Hong K.W. Cilostazol reduces brain lesion induced by focal cerebral ischemia in rats-an MRI study. Brain Res. 994 (2003) 91-98
23. Macdonald R.L., Marton L.S., Andrus P.K., Hall E.D., Johns L., and Sajdak M. Time course of production of hydroxyl free radical after subarachnoid hemorrhage in dogs. Life Sci. 75 (2004) 979-989
24. Matsumoto M. Cilostazol in secondary prevention of stroke: impact of the Cilostazol Stroke Prevention Study. Atheroscler Suppl. 6 (2005) 33-40
25. Nakajima M., Date I., Takahashi K., Ninomiya Y., Asari S., and Ohmoto T. Effects of aging on cerebral vasospasm after subarachnoid hemorrhage in rabbits. Stroke 32 (2001) 620-628
26. Onoue H., Kaito N., Akiyama M., Tomii M., Tokudome S., and Abe T. Altered reactivity of human cerebral arteries after subarachnoid hemorrhage. J. Neurosurg. 83 (1995) 510-515
27. Perkins E., Kimura H., Parent A.D., and Zhang J.H. Evaluation of the microvasculature and cerebral ischemia after experimental subarachnoid hemorrhage in dogs. J. Neurosurg. 97 (2002) 896-904
28. Sano K., Asano T., Tanishima T., and Sasaki T. Lipid peroxidation as a cause of cerebral vasospasm. Neurol. Res. 2 (1980) 253-272
29. Sehba F.A., Mostafa G., Friedrich V., and Bederson J.B. Acute microvascular platelet aggregation after subarachnoid hemorrhage. J. Neurosurg. 102 (2005) 1094-1100
30. Suzuki H., Kanamaru K., Tsunoda H., Inada H., Kuroki M., Sun H., Waga S., and Tanaka T. Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J. Clin. Invest. 104 (1999) 59-66
31. U-King-Im J.M., Trivedi R.A., Sala E., Graves M.J., Gaskarth M., Higgins N.J., Cross J.C., Hollingworth W., Coulden R.A., Kirkpatrick P.J., Antoun N.M., and Gillard J.H. Evaluation of carotid stenosis with axial high-resolution black-blood MR imaging. Eur. Radiol. 14 (2004) 1154-1161
32. Zhou C., Yamaguchi M., Kusaka G., Schonholz C., Nanda A., and Zhang J.H. Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 24 (2004) 419-431